Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data
Using comprehensive U.S. drug claims data, we show that adherence to asthma control medication declined during the COVID-19 pandemic. We find that young children exhibited a 40 percent decrease in adherence by the end of 2020. The responses were less negative for older children and positive for adults. We provide additional evidence that parental attention played a role in driving this decrease, based on heterogeneity by pre-pandemic mail order usage and the number of parental scripts. Policy implications for improving pediatric adherence are discussed.
-
-
Copy CitationJosh Feng, Matthew J. Higgins, and Elena Patel, "Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data," NBER Working Paper 30968 (2023), https://doi.org/10.3386/w30968.Download Citation
-
Published Versions
Josh Feng & Matthew J. Higgins & Elena Patel, 2026. "Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data," Health Economics, John Wiley & Sons, Ltd., vol. 35(2), pages 346-359, February, DOI: 10.1002/hec.70062. citation courtesy of ![]()
Josh Feng & Matthew J. Higgins & Elena Patel, 2026. "Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data," Health Economics, vol 35(2), pages 346-359.